Executive proposes new autonomous entity to replace the Digemid

Yesterday, the Commission of Infrastructure and Territorial Development of the Legislative Assembly ruled in favour of the initiative of the Executive that contains the bill to create the Directorate of national markets and commercial premises located in public spaces, a rule that will regulate trade in such buildings at the national level. The Directorate will be responsible for the administration of national markets, as well as commercial prem…

In response to recent questions to the Directorate-General for Medicines, Insumos and Drugs (Digemid), the Government presented to Congress a bill that proposes the creation of the National Authority for Pharmaceutical Products, Medical Devices and Health Products.As announced by the President of the Council of Ministers, Gustavo Adrianzén, this new entity will be a specialized technical body with administrative, functional, economic and budgeta…

Death lurks in every corner of PeruThe president of the Council of Ministers, Gustavo Adrianzén, reported that the government will replace the General Directorate of Medicines, Insumos and Drugs - Digemid by a new public agency, following the scandal of the deadly serum of Medifarma. "We send to Congress a bill that approves the National Authority of Pharmaceutical Products, Medical Devices and Health Products," he said before the press.Accordin…

The president of the Council of Ministers, Gustavo Adrianzén, reported that the Government has submitted to the Congress of the Republic a bill for the creation of a new agency, which will replace the General Directorate of Drugs, Insumes and Drugs (Digemid).It is, as indicated in a press conference, the National Authority of Pharmaceutical Products, Medical Devices and Health Products - (Apemed).This body, he detailed, will have the main functi…

At a conference of the Council of Ministers, Prime Minister Gustavo Adrianz announced that a bill had been sent to Congress approving a new national authority to replace DIGEID.